The effect of the Take Charge intervention on mood, motivation, activation and risk factor management: Analysis of secondary data from the Taking Charge after Stroke (TaCAS) trial.


Journal

Clinical rehabilitation
ISSN: 1477-0873
Titre abrégé: Clin Rehabil
Pays: England
ID NLM: 8802181

Informations de publication

Date de publication:
Jul 2021
Historique:
pubmed: 16 2 2021
medline: 22 7 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

To use secondary data from the Taking Charge after Stroke study to explore mechanisms for the positive effect of the Take Charge intervention on physical health, advanced activities of daily living and independence for people after acute stroke. An open, parallel-group, randomised trial with two active and one control intervention and blinded outcome assessment. Community. Adults ( One, two, or zero sessions of the Take Charge intervention, a self-directed rehabilitation intervention which helps a person with stroke take charge of their own recovery. Twelve months after stroke: Mood (Patient Health Questionnaire-2, Mental Component Summary of the Short Form 36); 'ability to Take Charge' using a novel measure, the Autonomy-Mastery-Purpose-Connectedness (AMP-C) score; activation (Patient Activation Measure); body mass index (BMI), blood pressure (BP) and medication adherence (Medication Adherence Questionnaire). Follow-up was near-complete (388/390 (99.5%)) of survivors at 12 months. Mean age (SD) was 72.0 (12.5) years. There were no significant differences in mood, activation, 'ability to Take Charge', medication adherence, BMI or BP by randomised group at 12 months. There was a significant positive association between baseline AMP-C scores and 12-month outcome for control participants (1.73 (95%CI 0.90 to 2.56)) but not for the Take Charge groups combined (0.34 (95%CI -0.17 to 0.85)). The mechanism by which Take Charge is effective remains uncertain. However, our findings support a hypothesis that baseline variability in motivation, mastery and connectedness may be modified by the Take Charge intervention.

Identifiants

pubmed: 33586474
doi: 10.1177/0269215521993648
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1021-1031

Auteurs

Harry McNaughton (H)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Mark Weatherall (M)

Department of Medicine, University of Otago, Wellington, New Zealand.

Kathryn McPherson (K)

Auckland University of Technology, Auckland, New Zealand.

Vivian Fu (V)

Medical Research Institute of New Zealand, Wellington, New Zealand.

William J Taylor (WJ)

Rehabilitation Teaching and Research Unit, University of Otago, Wellington, New Zealand.

Anna McRae (A)

Auckland District Health Board, Auckland, New Zealand.

Tom Thomson (T)

Hutt Valley District Health Board, Lower Hutt, New Zealand.

John Gommans (J)

Hawkes Bay District Health Board, Hastings, New Zealand.

Geoff Green (G)

Counties-Manukau District Health Board, Auckland, New Zealand.

Matire Harwood (M)

Te Kupenga Hauora Māori, University of Auckland, Auckland, New Zealand.

Annemarei Ranta (A)

Department of Medicine, University of Otago, Wellington, New Zealand.

Carl Hanger (C)

Canterbury District Health Board, Christchurch, New Zealand.

Judith Riley (J)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH